DIMETHYLSULFOXIMIN-DERIVAT

European patent · EP4166541 · In force

Register entry

Publication number
EP4166541
Application number
EP21820982
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 7, 2021
Published
Apr 19, 2023
Granted
Aug 5, 2026
Protection ends at the latest
Jun 6, 2041
Next annual fee due
Jun 30, 2027
IPC classes
C07D 213/71 (2006.01)
C07D 307/64 (2006.01)
C07D 231/18 (2006.01)
C07D 333/34 (2006.01)
C07D 263/46 (2006.01)
C07D 277/36 (2006.01)
A61K 31/175 (2006.01)
Priority
CN 202010528855 11.06.2020
CN 202010779149 05.08.2020
PCT application
PCT/CN2021/098601 07.06.2021
PCT publication
WO2021/249337 16.12.2021
Filing language
Chinese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 5, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 05.08.2026

Parties

Holder

Cisen Pharmaceutical Co.,Ltd

Tongji Sci-tech and Industrial Park National High-tech Industrial Development Zone Jining, Shandong 272073, CN

Inventor

QIAN, Wenyuan

Shanghai 200131, CN

LIAO, Yonggang

Shanghai 200131, CN

WEI, Changqing

Shanghai 200131, CN

XI, Zhengying

Shanghai 200131, CN

XIAO, Yao

Shanghai 200131, CN

CHEN, Shuhui

Shanghai 200131, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.